Literature DB >> 19343040

PKC-mediated phosphorylation regulates c-FLIP ubiquitylation and stability.

A Kaunisto1, V Kochin, T Asaoka, A Mikhailov, M Poukkula, A Meinander, J E Eriksson.   

Abstract

Cellular FLICE-inhibitory protein (c-FLIP) proteins are crucial regulators of the death-inducing signaling complex (DISC) and caspase-8 activation. To date, three c-FLIP isoforms with distinct functions and regulation have been identified. Our previous studies have shown that the stability of c-FLIP proteins is subject to isoform-specific regulation, but the underlying molecular mechanisms have not been known. Here, we identify serine 193 as a novel in vivo phosphorylation site of all c-FLIP proteins and demonstrate that S193 phosphorylation selectively influences the stability of the short c-FLIP isoforms, as S193D mutation inhibits the ubiquitylation and selectively prolongs the half-lives of c-FLIP short (c-FLIP(S)) and c-FLIP Raji (c-FLIP(R)). S193 phosphorylation also decreases the ubiquitylation of c-FLIP long (c-FLIP(L)) but, surprisingly, does not affect its stability, indicating that S193 phosphorylation has a different function in c-FLIP(L). The phosphorylation of this residue is operated by the protein kinase C (PKC), as S193 phosphorylation is markedly increased by treatment with 12-O-tetradecanoylphorbol-13-acetate and decreased by inhibition of PKCalpha and PKCbeta. S193 mutations do not affect the ability of c-FLIP to bind to the DISC, although S193 phosphorylation is increased by death receptor stimulation. Instead, S193 phosphorylation affects the intracellular level of c-FLIP(S), which then determines the sensitivity to death-receptor-mediated apoptosis. These results reveal that the differential stability of c-FLIP proteins is regulated in an isoform-specific manner by PKC-mediated phosphorylation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19343040     DOI: 10.1038/cdd.2009.35

Source DB:  PubMed          Journal:  Cell Death Differ        ISSN: 1350-9047            Impact factor:   15.828


  22 in total

1.  Glucocorticoid receptor antagonist sensitizes TRAIL-induced apoptosis in renal carcinoma cells through up-regulation of DR5 and down-regulation of c-FLIP(L) and Bcl-2.

Authors:  Kyoung-Jin Min; Ji Hoon Jang; Jung Tae Lee; Kyeong Sook Choi; Taeg Kyu Kwon
Journal:  J Mol Med (Berl)       Date:  2011-10-19       Impact factor: 4.599

2.  S-nitrosylation of FLICE inhibitory protein determines its interaction with RIP1 and activation of NF-κB.

Authors:  Siera Jo Talbott; Sudjit Luanpitpong; Christian Stehlik; Neelam Azad; Anand Krishnan V Iyer; Liying Wang; Yon Rojanasakul
Journal:  Cell Cycle       Date:  2014-04-24       Impact factor: 4.534

3.  Modeling reveals that dynamic regulation of c-FLIP levels determines cell-to-cell distribution of CD95-mediated apoptosis.

Authors:  Hannu T Toivonen; Annika Meinander; Tomoko Asaoka; Mia Westerlund; Frank Pettersson; Andrey Mikhailov; John E Eriksson; Henrik Saxén
Journal:  J Biol Chem       Date:  2011-02-15       Impact factor: 5.157

4.  USP8 suppresses death receptor-mediated apoptosis by enhancing FLIPL stability.

Authors:  M Jeong; E-W Lee; D Seong; J Seo; J-H Kim; S Grootjans; S-Y Kim; P Vandenabeele; J Song
Journal:  Oncogene       Date:  2016-06-20       Impact factor: 9.867

5.  The NEDD8-activating enzyme inhibitor, MLN4924, cooperates with TRAIL to augment apoptosis through facilitating c-FLIP degradation in head and neck cancer cells.

Authors:  Liqun Zhao; Ping Yue; Sagar Lonial; Fadlo R Khuri; Shi-Yong Sun
Journal:  Mol Cancer Ther       Date:  2011-09-13       Impact factor: 6.261

6.  FGF2-activated ERK mitogen-activated protein kinase enhances Runx2 acetylation and stabilization.

Authors:  Ok-Jin Park; Hyun-Jung Kim; Kyung-Mi Woo; Jeong-Hwa Baek; Hyun-Mo Ryoo
Journal:  J Biol Chem       Date:  2009-12-10       Impact factor: 5.157

7.  Model-based dissection of CD95 signaling dynamics reveals both a pro- and antiapoptotic role of c-FLIPL.

Authors:  Nicolai Fricker; Joel Beaudouin; Petra Richter; Roland Eils; Peter H Krammer; Inna N Lavrik
Journal:  J Cell Biol       Date:  2010-08-09       Impact factor: 10.539

Review 8.  c-FLIP, a master anti-apoptotic regulator.

Authors:  A R Safa
Journal:  Exp Oncol       Date:  2012-10

9.  Suppression of HSP70 expression sensitizes NSCLC cell lines to TRAIL-induced apoptosis by upregulating DR4 and DR5 and downregulating c-FLIP-L expressions.

Authors:  Hongqin Zhuang; Weiwei Jiang; Xiangyu Zhang; Fan Qiu; Ziyi Gan; Wei Cheng; Jing Zhang; Shengwen Guan; Bo Tang; Qilai Huang; Xinhua Wu; Xiaofeng Huang; Wenhui Jiang; Qingang Hu; Min Lu; Zi-Chun Hua
Journal:  J Mol Med (Berl)       Date:  2012-09-05       Impact factor: 4.599

10.  Novel phosphorylation and ubiquitination sites regulate reactive oxygen species-dependent degradation of anti-apoptotic c-FLIP protein.

Authors:  Rachel P Wilkie-Grantham; Shu-Ichi Matsuzawa; John C Reed
Journal:  J Biol Chem       Date:  2013-03-21       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.